-
Galloway accuser could not foresee publishing-sector fallout, lawyer argues
-
No. 22 UCLA defeats No. 5 Arizona 84-75 despite Kharchenkov's 38 points
-
New York City Center revives In the Heights as a timely community story
-
Vessel operator seeks witnesses after Vancouver grounding
-
Godzilla Minus Zero shifts focus toward postwar human drama
-
US Air Force deploys F-16 fighters to remote Aleutian base for readiness drill
-
Mehbooba Mufti urges dialogue and renewed Central Asia links for Kashmir
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Seacliff Healthcare Seeks Specialist GP in Thirroul
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
India proposes more import entry points for drugs and medical devices
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
-
NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
India and Israel oppose UN draft on regional conventional arms control
-
Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
-
BLS Polymers shares open 65.3% above IPO price
-
US Buildings Threatened by Wildfires Could Triple by 2060
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise
-
Latino Voters Defy ICE Fears, Turn Out in Record Numbers for Midterms
-
US Strikes Iranian Targets in Strait of Hormuz Ahead of Midterms
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Brodeur’s Overtime Goal Secures Bethlehem’s Second Consecutive Sectional Title
-
Reliance rally puts historical one-year return pattern in focus
-
Rare 1970 Plymouth ‘Cuda 426 Hemi Listed for $400,000
-
Kuwait edges Oman 1-0 in veterans Gulf Cup in Doha
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Alberta Tabled Controversial Riding Boundary Maps Amid Gerrymandering Accusations
-
Washington reports movement in Iran negotiations aimed at preventing escalation
-
Hong Kong court set to sentence activist Joshua Wong in security case
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
'The Remarried Empress' Cast Discusses Bringing Fantasy Royal Drama to Life
-
Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
John Schneider Admits Owes Millions in 'Dukes of Hazzard' Divorce Battle
-
Global failure to punish attacks leaves journalists at continuing risk
-
Philippine Authorities Report Progress in Thomas Markle Sr. Child Pornography Probe
Food or medicine? Stark choice for sick Argentines
In pharmacies in crisis-riddled Argentina, people look at the prices on medicine containers, then put them down again.
Even prescription antibiotics and chronic treatments are being ditched in a country where annual inflation exceeding 250 percent means that healthcare has become a luxury for many.
"Between eating and buying medicine, people choose to eat," pharmacist Marcela Lopez told AFP from behind her counter in the capital, Buenos Aires.
Medicine sales in the country dropped by 10 million units -- bottles or boxes -- in the month of January, according to the Ceprofar pharmacists' association. More than two-thirds were prescription drugs.
Desperate patients also feel abandoned by the public health system, where many medicines have become unavailable since the government of President Javier Milei, who took office in December, ordered an audit as part of his quest to slash public spending.
Viviana Bogado, a 53-year-old cook, said she had to choose between treatment for her cholesterol and antibiotics and special food for her 16-year-old son, Daniel, for an intestinal bacteria.
She put her son first.
Since self-styled "anarcho-capitalist" Milei took over, medicine prices have risen 40 percent above inflation, itself at 254 percent year-on-year and one of the highest in the world.
At the same time, poverty levels have reached nearly 60 percent in a country where the minimum salary is the equivalent of about $200.
According to Ceprofar director Ruben Sajem, there had been an agreement between laboratories and the pre-Milei government to keep prices low.
That has since been abandoned.
- 'There is no money' -
Pharmacists say many chronic patients were reducing their prescription doses to try and save money.
"This does not serve the patient. Sooner or later their health will worsen and everything will cost more, even for the (public) health system," said Sajem.
Worst hit are retired Argentines and workers in the informal sector, who account for 40 percent of the labor market.
The state pension devalued by a third year-on-year in February, making life difficult for people like 73-year-old Graciela Fuentes, who is having a hard time treating her arthritis.
The state provides pensioners with some medicines for free, others at subsidized prices.
"I take five remedies: two of which I get free of charge, I spend 85,000 pesos per month (about $100) -- almost a third of my pension. There is no money," said Fuentes in an ironic reference to Milei's oft-used justification for public spending cuts.
Fabian Furman, the head of a community medicines bank run by a Jewish foundation, told AFP there had been a massive increase in demand for free treatments.
- 'Pablo has no time' -
Pablo Riveros, 20, suffers from paroxysmal nocturnal hemoglobinuria, a rare, life-threatening disease for which there is no cure.
The treatment to alleviate his fast-worsening symptoms costs $42,000 a month, an impossible ask from his seamstress mother.
After his diagnosis in February last year, Riveros received medication from the public healthcare system. But that stopped in November.
Riveros's family went to court seeking relief, and were told "the state is not denying us medication, but we have to wait for the audit," his mother Estela Coronel told AFP.
The only problem, "Pablo has no time" to wait, weakening by the day.
Presidential spokesman Manuel Adorni last week denied that drug delivery to patients with cancer and other serious diseases such as Riveros had ever been cut off.
"It’s painful because you feel like they're laughing in your face," said Coronel.
"They cannot deny something that we are living."
T.Wright--AT